Identification of a metastasis signature and the DLX4 homeobox protein as a regulator of metastasis by combined transcriptome approach

Oncogene

Volumn 26, Issue 31, 2007, Pages 4600-4608

  Tomida, S ^a   Yanagisawa, K ^a   Koshikawa, K ^a   Yatabe, Y ^b   Mitsudomi, T ^b   Osada, H ^b   Takahashi, T ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

DLX4; Expression profile; Gene ontology; Lung cancer; Metastasis

Indexed keywords

HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DLX4; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL MOTILITY; CLONING; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE IDENTIFICATION; GENOMICS; HUMAN; HUMAN CELL; LUNG CANCER; MALE; METASTASIS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TRANSCRIPTOMICS;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION PROFILING; HOMEODOMAIN PROTEINS; HUMANS; LUNG NEOPLASMS; MICE; MICE, SCID; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 34447123918     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210242     Document Type: Article

References (29)

1. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM et al. (2000). Gene ontology: tool for the unification of biology The Gene Ontology Consortium. Nat Genet 25: 25-29.
2. Ayala G.E, Dai H, Ittmann M, Li R, Powell M, Frolov A et al. (2004). Growth and survival mechanisms associated with perineural invasion in prostate cancer. Cancer Res 64: 6082-6090.
3. Bernal JA, Luna R, Espina A, Lazaro I, Ramos-Morales F, Romero F et al. (2002). Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis. Nat Genet 32: 306-311.
4. Bobrovnikova-Marjon EV, Marjon PL, Barbash O, Vander Jagt DL, Abcouwer SF. (2004). Expression of angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 is highly responsive to ambient glutamine availability: role of nuclear factor-kappaB and activating protein-1. Cancer Res 64: 4858-citepn > 4869.
5. Cavallaro U, Christofori G. (2004). Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 4: 118-132.
6. Dasgupta B, Yi Y, Hegedus B, Weber JD, Gutmann DH. (2005). Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma. Cancer Res 65: 9843-9850.
7. Eisen MB, Spellman PT, Brown PO, Botstein D. (1998). Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95: 14863-14868.
8. Fidler IJ. (2003). The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3: 453-458.
9. Gallagher PG, Bao Y, Prorock A, Zigrino P, Nischt R, Politi V et al. (2005). Gene expression profiling reveals cross-talk between melanoma and fibroblasts: implications for hosttumor interactions in metastasis. Cancer Res 65: 4134-4146.
10. Gentleman RC, Lawless JF, Lindsey JC, Yan P. (1994). Multistate Markov models for analysing incomplete disease history data with illustrations for HIV disease. Stat Med 13: 805-821.
11. Glinsky GV, Berezovska O, Glinskii AB. (2005). Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 115: 1503-1521.
12. Goswami S, Wang W, Wyckoff JB, Condeelis JS. (2004). Breast cancer cells isolated by chemotaxis from primary tumors show increased survival and resistance to chemotherapy. Cancer Res 64: 7664-7667.
13. Heaney AP, Singson R, McCabe CJ, Nelson V, Nakashima M, Melmed S. (2000). Expression of pituitary-tumour transforming gene in colorectal tumours. Lancet 355: 716-719.
14. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A et al. (2005). Cancer statistics, 2005. CA Cancer J Clin 55: 10-30.
15. Jordan MA, Wilson L. (2004). Microtubules as a target for anticancer drugs. Nat Rev Cancer 4: 253-265.
16. Kang Y, Massague J. (2004). Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 118: 277-279.
17. Kim YH, Girard L, Giacomini CP, Wang P, Hernandez-Boussard T, Tibshirani R et al. (2006). Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification. Oncogene 25: 130-138.
18. Kozaki K, Miyaishi O, Tsukamoto T, Tatematsu Y, Hida T, Takahashi T. (2000). Establishment and characterization of a human lung cancer cell line NCI-H460-LNM35 with consistent lymphogenous metastasis via both subcutaneous and orthotopic propagation. Cancer Res 60: 2535-2540.
19. Liu FT, Rabinovich GA. (2005). Galectins as modulators of tumour progression. Nat Rev Cancer 5: 29-41.
20. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD et al. (2005). Genes that mediate breast cancer metastasis to lung. Nature 436: 518-524.
21. Miyamoto K, Fukutomi T, Akashi-Tanaka S, Hasegawa T, Asahara T, Sugimura T et al. (2005). Identification of 20 genes aberrantly methylated in human breast cancers. Int J Cancer 116: 407-414.
22. Morowitz MJ, Barr R, Wang Q, King R, Rhodin N, Pawel B et al. (2005). Methionine aminopeptidase 2 inhibition is an effective treatment strategy for neuroblastoma in preclinical models. Clin Cancer Res 11: 2680-2685.
23. Nicholson BE, Frierson HF, Conaway MR, Seraj JM, Harding MA, Hampton GM et al. (2004). Profiling the evolution of human metastatic bladder cancer. Cancer Res 64: 7813-7821.
24. Osada H, Takahashi T. (2002). Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Oncogene 21: 7421-7434.
25. Pantel K, Brakenhoff RH. (2004). Dissecting the metastatic cascade. Nat Rev Cancer 4: 448-456.
26. Quinn LM, Latham SE, Kalionis B. (1998). A distal-less class homeobox gene, DLX4, is a candidate for regulating epithelial-mesenchymal cell interactions in the human placenta. Placenta 19: 87-93.
27. Ramaswamy S, Ross KN, Lander ES, Golub TR. (2003). A molecular signature of metastasis in primary solid tumors. Nat Genet 33: 49-54.
28. Takeuchi T, Tomida S, Yatabe Y, Kosaka T, Osada H, Yanagisawa K et al. (2006). Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. J Clin Oncol 24: 1679-1688.
29. Tomida S, Koshikawa K, Yatabe Y, Harano T, Ogura N, Mitsudomi T et al. (2004). Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients. Oncogene 23: 5360-5370.